Get the Stockscreener App
2.15
2.87%
0.06
After Hours:
2.15
Health Catalyst Inc stock is traded at $2.15, with a volume of 984.07K.
It is up +2.87% in the last 24 hours and down -9.66% over the past month.
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
See More
Previous Close:
$2.09
Open:
$2.13
24h Volume:
984.07K
Relative Volume:
1.44
Market Cap:
$152.07M
Revenue:
$299.48M
Net Income/Loss:
$-86.45M
P/E Ratio:
-1.4333
EPS:
-1.5
Net Cash Flow:
$-17.32M
1W Performance:
+0.00%
1M Performance:
-9.66%
6M Performance:
-43.72%
1Y Performance:
-60.84%
1-Day Range:
$2.04
$2.18
1-Week Range:
$2.04
$2.37
52-Week Range:
$2.015
$5.858
Health Catalyst Inc Stock (HCAT) Company Profile
Name
Health Catalyst Inc
Sector
Industry
Phone
801-708-6800
Address
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Compare HCAT vs VEEV, TEM, BTSG, HQY, DOCS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HCAT
Health Catalyst Inc
|
2.15 | 147.83M | 299.48M | -86.45M | -17.32M | -1.50 |
|
VEEV
Veeva Systems Inc
|
183.65 | 30.22B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
54.91 | 9.33B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
BTSG
Brightspring Health Services Inc
|
39.68 | 6.92B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
79.45 | 6.77B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
27.73 | 6.27B | 550.17M | 201.35M | 232.07M | 1.00 |
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-27-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-11-25 | Downgrade | Citigroup | Buy → Neutral |
| Aug-08-25 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jun-17-25 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-09-25 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-08-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-10-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Jan-03-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-13-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-13-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Aug-01-23 | Initiated | Cantor Fitzgerald | Overweight |
| May-10-23 | Downgrade | Guggenheim | Buy → Neutral |
| May-10-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-20-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-12-23 | Initiated | Stephens | Equal-Weight |
| Apr-04-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-31-22 | Initiated | Wells Fargo | Equal Weight |
| Oct-25-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-13-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-05-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-05-22 | Downgrade | Stifel | Buy → Hold |
| Apr-14-22 | Initiated | Guggenheim | Buy |
| Mar-17-22 | Upgrade | Jefferies | Hold → Buy |
| Feb-11-22 | Initiated | Goldman | Buy |
| Dec-02-21 | Initiated | Jefferies | Hold |
| Oct-14-21 | Initiated | BTIG Research | Buy |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Dec-08-20 | Initiated | Berenberg | Buy |
| Jul-14-20 | Initiated | Citigroup | Buy |
| Jun-18-20 | Initiated | Stifel | Buy |
| Jun-15-20 | Resumed | Evercore ISI | Outperform |
| May-15-20 | Initiated | Guggenheim | Buy |
| Apr-21-20 | Initiated | RBC Capital Mkts | Outperform |
| Apr-13-20 | Initiated | SVB Leerink | Outperform |
| Apr-02-20 | Initiated | Canaccord Genuity | Buy |
| Dec-20-19 | Initiated | Raymond James | Strong Buy |
| Oct-30-19 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-19-19 | Initiated | Evercore ISI | Outperform |
| Aug-19-19 | Initiated | Goldman | Buy |
| Aug-19-19 | Initiated | JP Morgan | Overweight |
| Aug-19-19 | Initiated | Piper Jaffray | Overweight |
| Aug-19-19 | Initiated | SVB Leerink | Outperform |
| Aug-19-19 | Initiated | SunTrust | Buy |
| Aug-19-19 | Initiated | William Blair | Outperform |
View All
Health Catalyst Inc Stock (HCAT) Latest News
3 of Wall Street's Favorite Stocks We Approach with Caution - Finviz
Marquis Who's Who Honors Kristin Acree for Expertise in Public Health - lelezard.com
Why Health Catalyst (HCAT) Stock Is Trading Lower Today - Finviz
How Health Catalyst Turns Analytics Into Action Clinicians Actually Use - Healthcare IT Today
Bear Alert: What is the cash position of GOGOQuarterly Portfolio Review & Risk Managed Trade Strategies - baoquankhu1.vn
Health Catalyst, Inc (HCAT) Stock Analysis: Exploring a Compelling 76.94% Upside Potential - DirectorsTalk Interviews
Here's Why Health Catalyst (HCAT) Is a Great 'Buy the Bottom' Stock Now - Yahoo Finance
Analyst Calls: What is the dividend yield of Snowflake IncJuly 2025 Momentum & Long-Term Growth Portfolio Plans - baoquankhu1.vn
How The New Price Target Is Reframing Health Catalyst’s Story And Fair Value - Yahoo Finance
Support Test: Should I set a stop loss on Health Catalyst IncJuly 2025 Market Mood & Daily Growth Stock Tips - baoquankhu1.vn
Navigating 2026: How health systems can thrive amid AI, labor and consumer pressures - Modern Healthcare
Health Catalyst, Inc. (NASDAQ:HCAT) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Health Catalyst Announces Chief Commercial Officer Transition Plan - TipRanks
Health Catalyst, Inc. Announces Executive Changes - marketscreener.com
Health Catalyst, MongoDB, Asana, Domo, and RingCentral Stocks Trade Up, What You Need To Know - The Globe and Mail
Health Catalyst, Inc (HCAT) Stock Analysis: Evaluating the 68% Potential Upside for Investors - DirectorsTalk Interviews
Why Clinical Data Analytics Is Becoming One of Healthcare’s Fastest-Growing Markets? - GlobeNewswire Inc.
Q3 Earnings Highs And Lows: Health Catalyst (NASDAQ:HCAT) Vs The Rest Of The Data Analytics Stocks - Barchart.com
Nasdaq Moves: What are Health Catalyst Incs recent SEC filings showingMarket Movers & Daily Chart Pattern Signals - baoquankhu1.vn
Health Catalyst, Veeva Systems, 8x8, Amplitude, and DocuSign Stocks Trade Down, What You Need To Know - The Globe and Mail
Market Outlook: Can Health Catalyst Inc stock weather global recessionStop Loss & Risk Managed Investment Strategies - Bộ Nội Vụ
Health Catalyst stock reiterated as Buy at Stifel despite 2026 revenue guide - Investing.com Australia
Health Catalyst stock reiterated as Buy at Stifel despite 2026 revenue guide By Investing.com - Investing.com South Africa
HCAT Projects Strong Client Growth and EBITDA Goals for FY25 - GuruFocus
(HCAT) Health Catalyst Expects 2025 Revenue to Slightly Exceed Guidance of About $310 Million - marketscreener.com
Health Catalyst drives AI in healthcare to cut costs - Traders Union
Surprises Report: Is Health Catalyst Inc stock a top pick in earnings seasonJuly 2025 Outlook & Verified Swing Trading Watchlists - moha.gov.vn
Health Catalyst examines AI's tangible impact on healthcare - Traders Union
4 Analysts Have This To Say About Health Catalyst - Benzinga
HCAT: Citigroup Adjusts Price Target, Maintains Neutral Rating | - GuruFocus
Is Health Catalyst Inc. stock positioned well for digital economyWalking Comfort Picks & what to check before ordering - Улправда
Is Health Catalyst Inc. stock a top pick in earnings seasonJuly 2025 PreEarnings & Low Risk High Win Rate Picks - Улправда
How Health Catalyst Inc. stock compares to growth peers2025 Fundamental Recap & AI Powered Market Entry Strategies - Улправда
Can Health Catalyst Inc. stock rebound after recent weaknessMarket Rally & AI Driven Stock Movement Reports - Улправда
Is Health Catalyst Inc. stock a dividend growth opportunityJuly 2025 Action & Free Low Drawdown Momentum Trade Ideas - Улправда
Is Health Catalyst Inc. stock oversold or undervaluedMarket Risk Summary & Technical Pattern Alert System - Улправда
EPS Watch: Is Health Catalyst Inc stock positioned well for digital economy2025 Market Sentiment & Free Expert Approved Momentum Trade Ideas - Bộ Nội Vụ
3 Russell 2000 Stocks Walking a Fine Line - Finviz
3 Value Stocks We Find Risky - Finviz
Signal Recap: Is Health Catalyst Inc stock oversold or undervaluedGap Down & Weekly High Return Stock Opportunities - moha.gov.vn
Investor Mood: Can Health Catalyst Inc stock rebound after recent weaknessWeekly Stock Analysis & Safe Entry Point Identification - Bộ Nội Vụ
3 Stocks Under $10 We're Skeptical Of - Finviz
Health Catalyst Inc Stock (HCAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Health Catalyst Inc Stock (HCAT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Larson-Green Julie | Director |
Dec 04 '25 |
Sale |
2.67 |
47,997 |
128,349 |
73,573 |
5.14%
1.95%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):